STAT1 (P42224) variants and mutations
STAT1 (also known as P42224) is a human protein-coding gene encoding a signal transducer and activator of transcription 1-alpha/beta protein. It executes interferon-driven transcriptional programs required for antiviral and antimycobacterial immunity. Loss-of-function variants can cause severe infectious susceptibility, whereas gain-of-function variants classically cause chronic mucocutaneous candidiasis and autoimmunity. This analysis covers 1,056 STAT1 variants and mutations. Of these, 47% have computational variant effect predictions. Disease context includes Chronic mucocutaneous candidosis, immunodeficiency 31B, and autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections. Example STAT1 variants include M1?, S2A, and Q3*.
Variant analysis overview
- Gene: STAT1
- Protein: P42224
- UniProt accession: P42224
- Organism: Homo sapiens
- Variants analyzed: 1056
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 897 unspecified-consequence records; 3 stop lost; 72 missense variants; 11 frameshift variants; 56 synonymous variants; 3 stop-gained variants; 1 splice-region variants; 2 in-frame deletions; 1 protein altering variant; 10 substitution
- Prediction scores: 492 variants have prediction scores (47% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Chronic mucocutaneous candidosis, immunodeficiency 31B, autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections, Susceptibility to viral and mycobacterial infections, cancer, Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections s, immunodeficiency disease, combined immunodeficiency, severe combined immunodeficiency, infantile cataract, skin abnormalities, glutamate excess, and impaired intellect, chronic mucocutaneous candidiasis, genetic developmental and epileptic encephalopathy.
Protein structure and variant hotspots
- Protein features: 1 domains; 15 post-translational modification sites.
- Structural context: 154 variants have structural context.
- PTM context: 43 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable STAT1 variants
Examples include M1?, S2A, Q3*, Q3P, Q3R, W4C, Y5*, E6D. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV63116
- S2A (p.Ser2Ala), ExAC rs750529832, gnomAD rs750529832, REVEL 0.08, CADD 16.40
- Q3* (p.Gln3Ter), rs1258563739, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, gnomAD rs1258563739, CADD 40.00, Variant assessed as somatic; high impact.
- Q3P (p.Gln3Pro), Ensembl rs1695000486
- Q3R (p.Gln3Arg), cosmic curated COSV63116
- W4C (p.Trp4Cys), gnomAD rs1233778383, REVEL 0.93, CADD 30.00
- Y5* (p.Tyr5Ter), cosmic curated COSV10890
- E6D (p.Glu6Asp), rs986212030, ClinGen CA62691419, ClinVar RCV001142684, TOPMed rs986212030, REVEL 0.08, CADD 14.40, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- E6K (p.Glu6Lys), rs761876441, ClinGen CA2030331, NCI-TCGA Cosmic COSV6311, cosmic curated COSV63116, REVEL 0.11, CADD 22.70, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Q9* (p.Gln9Ter), rs2470570568, ClinGen CA349928586, ClinVar RCV003224739, CADD 41.00, Pathogenic
- D11N (p.Asp11Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K13E (p.Lys13Glu), TOPMed rs1694999309
- K13R (p.Lys13Arg), rs2470570537, ClinGen CA349928534, ClinVar RCV003810287, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- Q17E (p.Gln17Glu), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Variant assessed as somatic; moderate impact.
- Q20* (p.Gln20Ter), cosmic curated COSV10745
- D23H (p.Asp23His), cosmic curated COSV10745
- D23V (p.Asp23Val), rs1694998227, ClinGen CA349928404, ClinVar RCV001240318, Ensembl rs1694998227, AlphaMissense 0.91, MetaLR 0.36, Uncertain significance, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- D24G (p.Asp24Gly), cosmic curated COSV10820
- P27S (p.Pro27Ser), cosmic curated COSV63116
- P27T (p.Pro27Thr), Ensembl rs11549696
- M28G (p.Met28Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E29Q (p.Glu29Gln), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- I30T (p.Ile30Thr), rs34255470, UniProt VAR 034521, Ensembl rs34255470, AlphaMissense 0.96, MetaLR 0.36
- I30V (p.Ile30Val), rs2470570384, ClinGen CA349928310, ClinVar RCV003806838, REVEL 0.13, CADD 17.10, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Q32* (p.Gln32Ter), Ensembl rs1694995981
- A35G (p.Ala35Gly), Ensembl rs1694995511
- W37C (p.Trp37Cys), cosmic curated COSV63115
- E39Q (p.Glu39Gln), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Variant assessed as somatic; moderate impact.
- E39V (p.Glu39Val), cosmic curated COSV63116
- W43* (p.Trp43Ter), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Ensembl rs2125101126, Variant assessed as somatic; high impact.
- W43R (p.Trp43Arg), cosmic curated COSV63117
- E44* (p.Glu44Ter), Ensembl rs2125101115
- E44D (p.Glu44Asp), rs2125101106, ClinGen CA349928148, ClinVar RCV003796852, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- H45Q (p.His45Gln), cosmic curated COSV63117
- H45Y (p.His45Tyr), Ensembl rs2125101101
- A46S (p.Ala46Ser), ExAC rs781389511, gnomAD rs781389511, REVEL 0.31, CADD 25.60
- A46T (p.Ala46Thr), rs781389511, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, ExAC rs781389511, REVEL 0.28, CADD 26.50, Variant assessed as somatic; moderate impact.
- A46V (p.Ala46Val), Ensembl rs2125101073
- A47T (p.Ala47Thr), NCI-TCGA TCGA novel, Ensembl rs2125101045, REVEL 0.27, CADD 24.30, Variant assessed as somatic; moderate impact.
- A47V (p.Ala47Val), Ensembl rs2125101035
- N48S (p.Asn48Ser), rs1410517497, ClinGen CA349928124, ClinVar RCV002967075, TOPMed rs1410517497, REVEL 0.08, CADD 14.70, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- V50A (p.Val50Ala), Ensembl rs112964697
- S51L (p.Ser51Leu), rs865962653, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Ensembl rs865962653, AlphaMissense 0.71, MetaLR 0.39, Variant assessed as somatic; moderate impact.
- A53P (p.Ala53Pro), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Variant assessed as somatic; moderate impact.
- A53V (p.Ala53Val), Ensembl rs2125100978
- T54I (p.Thr54Ile), Ensembl rs868260695
- R56C (p.Arg56Cys), TOPMed rs541089913, gnomAD rs541089913, REVEL 0.07, CADD 23.40
- R56H (p.Arg56His), rs1473494120, ClinGen CA349928074, NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, REVEL 0.21, CADD 24.40, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- F57L (p.Phe57Leu), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63117, Variant assessed as somatic; moderate impact.
- H58Y (p.His58Tyr), rs751586208, ClinGen CA2030311, cosmic curated COSV10820, ClinVar RCV001963604, REVEL 0.41, CADD 28.70, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- L60F (p.Leu60Phe), rs2125100882, ClinGen CA349928046, ClinVar RCV001997079, Ensembl rs2125100882, AlphaMissense 0.52, MetaLR 0.27, Uncertain significance, Immunodeficiency 31B; Mendelian susceptibility to mycobacterial diseases due to
- L61M (p.Leu61Met), cosmic curated COSV10820
- S62* (p.Ser62Ter), rs2470565458, ClinGen CA349928034, ClinVar RCV003989923, Likely pathogenic
- S62T (p.Ser62Thr), gnomAD rs1694923427, REVEL 0.07, CADD 19.20
- Q63* (p.Gln63Ter), Ensembl rs2125100847
- Q63R (p.Gln63Arg), rs2125100837, ClinGen CA349928028, ClinVar RCV001473108, Ensembl rs2125100837, REVEL 0.42, CADD 26.90, Likely benign, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- D65G (p.Asp65Gly), rs2470565379, ClinGen CA349928014, ClinVar RCV002824209, Conflicting interpretations, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- D65N (p.Asp65Asn), rs1574672739, ClinGen CA349928018, ClinVar RCV000821803, Ensembl rs1574672739, AlphaMissense 0.89, MetaLR 0.26, Uncertain significance, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- Q67* (p.Gln67Ter), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63116, Variant assessed as somatic; high impact.
- Q67K (p.Gln67Lys), NCI-TCGA Cosmic COSV6311, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Q67P (p.Gln67Pro), rs2470565369, ClinGen CA349927999, ClinVar RCV003018891, Pathogenic, Immunodeficiency 31B; Mendelian susceptibility to mycobacterial diseases due to
- Q67R (p.Gln67Arg), rs2470565369, ClinGen CA349927998, ClinVar RCV003025115, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Y68C (p.Tyr68Cys), rs2470565348, ClinGen CA349927990, ClinVar RCV003797443, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- R70C (p.Arg70Cys), rs2470565317, ClinGen CA349927976, ClinVar RCV003061538, NCI-TCGA Cosmic COSV1007, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- R70G (p.Arg70Gly), rs2470565317, ClinGen CA349927977, ClinVar RCV003809647, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- R70H (p.Arg70His), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- R70P (p.Arg70Pro), rs1574672718, ClinGen CA349927973, ClinVar RCV001027622, Ensembl rs1574672718, AlphaMissense 1.00, MetaLR 0.39, Likely pathogenic, Inherited Immunodeficiency Diseases
- F71I (p.Phe71Ile), Ensembl rs2125100774
- F71L (p.Phe71Leu), Ensembl rs2125100774
- F71V (p.Phe71Val), Ensembl rs2125100774
- S72Y (p.Ser72Tyr), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- L73F (p.Leu73Phe), cosmic curated COSV10073, REVEL 0.12, CADD 23.70
- E74K (p.Glu74Lys), cosmic curated COSV63115
- N76S (p.Asn76Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F77L (p.Phe77Leu), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- Q80* (p.Gln80Ter), gnomAD rs1230312731, CADD 39.00
- N82K (p.Asn82Lys), rs1694920831, ClinGen CA349927885, ClinVar RCV001045359, Ensembl rs1694920831, AlphaMissense 0.98, MetaLR 0.22, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- I83M (p.Ile83Met), TOPMed rs1293185041, gnomAD rs1293185041, REVEL 0.29, CADD 22.60
- R84K (p.Arg84Lys), cosmic curated COSV63116
- R84M (p.Arg84Met), cosmic curated COSV10073
- S86T (p.Ser86Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K87N (p.Lys87Asn), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- R88C (p.Arg88Cys), cosmic curated COSV63115
- R88H (p.Arg88His), rs1227143332, gnomAD rs1227143332, REVEL 0.17, CADD 23.30, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- L90V (p.Leu90Val), Ensembl rs1694919511, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Q91* (p.Gln91Ter), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Variant assessed as somatic; high impact.
- Q91H (p.Gln91His), cosmic curated COSV10073
- Q91L (p.Gln91Leu), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- D92G (p.Asp92Gly), cosmic curated COSV10820
- N93S (p.Asn93Ser), ExAC rs771067490, TOPMed rs771067490, gnomAD rs771067490, REVEL 0.06, CADD 21.30
- N93Y (p.Asn93Tyr), cosmic curated COSV10650
- F94V (p.Phe94Val), cosmic curated COSV63116
- P98A (p.Pro98Ala), Ensembl rs756147217, REVEL 0.90, CADD 27.40
- P98S (p.Pro98Ser), Ensembl rs756147217
- I99V (p.Ile99Val), rs1694805838, ClinGen CA349927374, cosmic curated COSV63116, ClinVar RCV003790978, REVEL 0.05, CADD 9.43, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- I105M (p.Ile105Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E111K (p.Glu111Lys), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- K114E (p.Lys114Glu), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Variant assessed as somatic; moderate impact.
- K114N (p.Lys114Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K114R (p.Lys114Arg), Ensembl rs111550607
- N118S (p.Asn118Ser), gnomAD rs1268196215, REVEL 0.10, CADD 15.90
- N118Y (p.Asn118Tyr), gnomAD rs1434958612, REVEL 0.06, CADD 22.30
- A119S (p.Ala119Ser), TOPMed rs1482374494, gnomAD rs1482374494, REVEL 0.33, CADD 25.80, Uncertain significance
- A119T (p.Ala119Thr), rs1482374494, ClinGen CA349927226, cosmic curated COSV63115, ClinVar RCV003789720, REVEL 0.43, CADD 27.20, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Q120* (p.Gln120Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q120E (p.Gln120Glu), rs1694803399, ClinGen CA349927219, ClinVar RCV001051390, Ensembl rs1694803399, AlphaMissense 0.08, MetaLR 0.08, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- R121I (p.Arg121Ile), NCI-TCGA Cosmic COSV1007, NCI-TCGA Cosmic COSV6311, cosmic curated COSV63114, Variant assessed as somatic; moderate impact.
- R121K (p.Arg121Lys), cosmic curated COSV10073
- N123H (p.Asn123His), ExAC rs748138919, gnomAD rs748138919, REVEL 0.18, CADD 19.50
- N123S (p.Asn123Ser), rs778751233, ClinGen CA2030271, ClinVar RCV001962758, ExAC rs778751233, REVEL 0.07, CADD 16.40, Uncertain significance, Immunodeficiency 31B; Mendelian susceptibility to mycobacterial diseases due to
- Q124P (p.Gln124Pro), TOPMed rs1476328098, gnomAD rs1476328098, REVEL 0.45, CADD 27.80
- Q124R (p.Gln124Arg), cosmic curated COSV63115, TOPMed rs1476328098, gnomAD rs1476328098, REVEL 0.35, CADD 28.20
- Q126H (p.Gln126His), ExAC rs778997004, gnomAD rs778997004, REVEL 0.18, CADD 15.10, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Q126R (p.Gln126Arg), ExAC rs748265365, gnomAD rs748265365, REVEL 0.16, CADD 17.40
- S127L (p.Ser127Leu), rs768483703, ClinGen CA2030251, ClinVar RCV000706821, ClinVar RCV004735761, REVEL 0.12, CADD 13.90, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- G128R (p.Gly128Arg), TOPMed rs1694239967
- I130T (p.Ile130Thr), rs1694239561, ClinGen CA349925535, cosmic curated COSV63117, ClinVar RCV001206843, AlphaMissense 0.10, MetaLR 0.41, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- S132G (p.Ser132Gly), Ensembl rs1219815154, REVEL 0.12, CADD 18.80
- T133A (p.Thr133Ala), gnomAD rs1397948697
- V134L (p.Val134Leu), rs1269987554, ClinGen CA349925464, ClinVar RCV002795058, TOPMed rs1269987554, REVEL 0.06, CADD 17.00, Uncertain significance, Immunodeficiency 31B; Mendelian susceptibility to mycobacterial diseases due to
- M135K (p.Met135Lys), cosmic curated COSV63115
- M135V (p.Met135Val), cosmic curated COSV10820
- D137A (p.Asp137Ala), ExAC rs749245387, TOPMed rs749245387, gnomAD rs749245387, REVEL 0.13, CADD 24.00
- D137E (p.Asp137Glu), 1000Genomes rs535073025, ExAC rs535073025, gnomAD rs535073025, REVEL 0.04, CADD 17.20
- D137N (p.Asp137Asn), cosmic curated COSV10820
- D143E (p.Asp143Glu), rs780853224, ClinGen CA349925280, ClinVar RCV001874689, ClinVar RCV005742288, REVEL 0.10, CADD 15.20, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- S144C (p.Ser144Cys), cosmic curated COSV10582
- S144I (p.Ser144Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S144N (p.Ser144Asn), gnomAD rs1472778655, REVEL 0.07, CADD 9.13
- K145R (p.Lys145Arg), rs2125079464, ClinGen CA349925264, ClinVar RCV002008679, Ensembl rs2125079464, AlphaMissense 0.08, MetaLR 0.29, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- R147G (p.Arg147Gly), ExAC rs751041198, gnomAD rs751041198, REVEL 0.28, CADD 22.40
- V149G (p.Val149Gly), ExAC rs763588438, gnomAD rs763588438, REVEL 0.64, CADD 31.00
- D151N (p.Asp151Asn), Ensembl rs866650146, REVEL 0.06, CADD 19.90
- K152E (p.Lys152Glu), gnomAD rs1243375266, REVEL 0.08, CADD 18.70
- M154L (p.Met154Leu), NCI-TCGA Cosmic COSV1007, NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- M154T (p.Met154Thr), cosmic curated COSV63115, 1000Genomes rs149388191, ESP rs149388191, ExAC rs149388191, REVEL 0.11, CADD 23.00, Uncertain significance, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- M154V (p.Met154Val), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, NCI-TCGA Cosmic COSV6311, Variant assessed as somatic; moderate impact.
- C155G (p.Cys155Gly), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10073, Variant assessed as somatic; moderate impact.
- C155R (p.Cys155Arg), rs373784601, ClinGen CA2030217, ClinVar RCV003795583, ClinVar RCV005495634, REVEL 0.12, CADD 16.90, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- I156T (p.Ile156Thr), rs2470526759, ClinGen CA349924508, ClinVar RCV003780993, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- I156V (p.Ile156Val), cosmic curated COSV63115, REVEL 0.05, CADD 18.50
- H158P (p.His158Pro), Ensembl rs2125075183
- H158Q (p.His158Gln), rs778997004, []
- I160L (p.Ile160Leu), rs371548986, ClinGen CA2030216, ClinVar RCV000803708, ClinVar RCV001337083, REVEL 0.19, CADD 22.80, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- I160V (p.Ile160Val), cosmic curated COSV10073
- K161Q (p.Lys161Gln), Ensembl rs2125075166
- S162I (p.Ser162Ile), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63117, Variant assessed as somatic; moderate impact.
- E164K (p.Glu164Lys), cosmic curated COSV10466
- D165A (p.Asp165Ala), cosmic curated COSV63117
- D165G (p.Asp165Gly), rs387906764, ClinGen CA128936, ClinVar RCV000022992, UniProt VAR 065934, AlphaMissense 0.90, MetaLR 0.72, Pathogenic, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- D165H (p.Asp165His), rs387906767, ClinGen CA128942, ClinVar RCV000022995, ClinVar RCV005416109, AlphaMissense 0.96, MetaLR 0.71, Likely pathogenic, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- D165V (p.Asp165Val), Ensembl rs387906764, Pathogenic, in IMD31C
- Q167H (p.Gln167His), rs1167103580, ClinGen CA349924427, ClinVar RCV003140429, Uncertain significance, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- Q167P (p.Gln167Pro), rs2470526576, ClinGen CA349924430, ClinVar RCV003337921, Uncertain significance, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- Q167R (p.Gln167Arg), NCI-TCGA Cosmic COSV6311, cosmic curated COSV63115, Variant assessed as somatic; moderate impact.
- D168G (p.Asp168Gly), cosmic curated COSV63117
- D168H (p.Asp168His), cosmic curated COSV63115
- E169* (p.Glu169Ter), NCI-TCGA Cosmic COSV6311, Variant assessed as somatic; high impact.
- E169K (p.Glu169Lys), cosmic curated COSV63116
- E169V (p.Glu169Val), rs2470526541, ClinGen CA349924412, ClinVar RCV002834134, Uncertain significance, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- Y170N (p.Tyr170Asn), rs387906766, ClinGen CA128940, ClinVar RCV000022994, UniProt VAR 065936, AlphaMissense 0.72, MetaLR 0.33, Pathogenic, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- D171H (p.Asp171His), rs2125075054, ClinGen CA349924400, ClinVar RCV003486380, AlphaMissense 0.91, MetaLR 0.45, Likely pathogenic, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- D171N (p.Asp171Asn), rs2125075054, ClinGen CA349924402, ClinVar RCV002003654, Ensembl rs2125075054, AlphaMissense 0.91, MetaLR 0.45, Likely pathogenic, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- F172L (p.Phe172Leu), rs2470526475, ClinGen CA349924387, ClinVar RCV003800234, cosmic curated COSV63116, Likely pathogenic, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficien
- K173I (p.Lys173Ile), rs1553497886, ClinGen CA349924383, ClinVar RCV000522452, Ensembl rs1553497886, AlphaMissense 0.81, MetaLR 0.45, Likely pathogenic, not provided
- C174R (p.Cys174Arg), rs387906763, UniProt VAR 065937, Ensembl rs387906763, AlphaMissense 0.20, MetaLR 0.12, Likely pathogenic, Inherited Immunodeficiency Diseases
- Q178P (p.Gln178Pro), cosmic curated COSV10820
- Q178R (p.Gln178Arg), rs2125074995, ClinGen CA349924346, ClinVar RCV001993775, Ensembl rs2125074995, AlphaMissense 0.14, MetaLR 0.24, Uncertain significance, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- N179K (p.Asn179Lys), rs587777628, ClinGen CA170566, ClinVar RCV000133513, UniProt VAR 075494, AlphaMissense 0.66, MetaLR 0.17, Likely pathogenic, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- N179S (p.Asn179Ser), rs774611299, ClinGen CA2030214, ClinVar RCV000986962, ExAC rs774611299, REVEL 0.10, CADD 15.70, Uncertain significance, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections
- R180G (p.Arg180Gly), Ensembl rs1694113314
- R180K (p.Arg180Lys), TOPMed rs1375484778, gnomAD rs1375484778, REVEL 0.18, CADD 23.30, Conflicting interpretations, Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility
- R180T (p.Arg180Thr), cosmic curated COSV63117
- H182Q (p.His182Gln), gnomAD rs890092776
- E183K (p.Glu183Lys), rs1430662949, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10069, TOPMed rs1430662949, REVEL 0.22, CADD 22.20, Variant assessed as somatic; moderate impact.
- T184A (p.Thr184Ala), gnomAD rs1694000715, REVEL 0.05, CADD 0.92
- T184I (p.Thr184Ile), NCI-TCGA Cosmic COSV6118, cosmic curated COSV61189, Variant assessed as somatic; moderate impact.
- N185S (p.Asn185Ser), rs1051397529, ClinGen CA62683355, cosmic curated COSV61189, ClinVar RCV001990029, REVEL 0.07, CADD 15.70, Uncertain significance, Immunodeficiency 31B; Mendelian susceptibility to mycobacterial diseases due to
- G186R (p.Gly186Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G186V (p.Gly186Val), cosmic curated COSV61190
Public STAT1 analysis runs
- STAT1 analysis run — STAT1 (1,056 variants) — completed 2026-08-18